{
  "docId": "019de076-7d6c-774e-85e8-ffe50da37251",
  "docSlug": "0b0d701714d17efa78c23c196990e90c",
  "documentTitle": "Genelux | Investor Presentation Deck | 37 slides",
  "authorId": "genelux",
  "authorName": "Genelux",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 37,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "go_to_market",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a hub-and-spoke style layout to categorize strategic pillars.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/22",
  "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251",
  "deckJsonHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251.json",
  "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.25,
        "y": 0.125
      },
      "kind": "callout",
      "text": "Drivers of Market Penetration",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1583bf29-9c4c-4d64-bdb0-85e034499188",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.2,
        "x": 0.75,
        "y": 0.3
      },
      "kind": "list",
      "text": "Reimbursement: Compelling Value Proposition for Payors. Significant unmet medical need. Combination with generic/biosimilars. Future label expansion.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "18efbe70-cc30-40db-87a2-4a53a61c7cb7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.2,
        "x": 0.53,
        "y": 0.3
      },
      "kind": "list",
      "text": "Patients: Underappreciated Population. ~236,511 PRROC Patients. 70-80% will relapse with few therapeutic options. Limited number of Gyn-Oncs enabling specialty sales team.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c063b76-91cd-4c79-9f71-1c6d41eaf634",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.2,
        "x": 0.3,
        "y": 0.3
      },
      "kind": "list",
      "text": "Self-Manufacturing: Large-Scale cGMP Manufacturing. Control of Production Schedule. Attractive COGs. Ability to scale up modular process.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8f5e808-3ac0-4301-a72e-006ed7221aac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.2,
        "x": 0.07,
        "y": 0.3
      },
      "kind": "list",
      "text": "Partnerships: Leverage partnership with GOG Foundation. Preeminent US-based cooperative group in Gynecologic Oncology. Composed of leading KOLs in the field. Partners in the OnPrime/GOG-3076 Phase 3 registration trial.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be4942e1-d6ac-4bde-863b-21d0350fc75d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.25,
        "y": 0.85
      },
      "kind": "metric",
      "text": "~350M annual revenue (est.)",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d266105-a13a-4ba7-8ccb-c733d21fed16",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Self Launch Olvi-Vec for Ovarian Cancer in the US",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c54f2ef1-2e9f-43c1-90c6-92cf5d3eb200",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "Strategic Pillars",
      "slug": null,
      "matchId": "9219d14a-8929-4bc2-982c-aa047dcba365",
      "evidence": "Four distinct categories driving market penetration",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 23,
      "from": 22,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "61b2324e-9c9a-4af0-b186-77775240e948",
      "evidence": "The loop opens by presenting the potential for self-launch and closes by highlighting the integrated R&D and manufacturing capabilities.",
      "position": 1,
      "objective": "Present a quick win and big bet",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}